nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells
|
Van Wassenhove, Lauren D. |
|
2016 |
119 |
1-2 |
p. 28-36 9 p. |
artikel |
2 |
Ammonium accumulation is a primary effect of 2-methylcitrate exposure in an in vitro model for brain damage in methylmalonic aciduria
|
Cudré-Cung, Hong-Phuc |
|
2016 |
119 |
1-2 |
p. 57-67 11 p. |
artikel |
3 |
Apelin/APJ system as a therapeutic target in diabetes and its complications
|
Hu, Haoliang |
|
2016 |
119 |
1-2 |
p. 20-27 8 p. |
artikel |
4 |
CBP/p300 acetyltransferase activity in hematologic malignancies
|
Dutta, Ritika |
|
2016 |
119 |
1-2 |
p. 37-43 7 p. |
artikel |
5 |
Development of a model system for neuronal dysfunction in Fabry disease
|
Kaneski, Christine R. |
|
2016 |
119 |
1-2 |
p. 144-150 7 p. |
artikel |
6 |
Diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Expert recommendations for early detection and laboratory diagnosis
|
Fietz, Michael |
|
2016 |
119 |
1-2 |
p. 160-167 8 p. |
artikel |
7 |
DNA methylation in the pathophysiology of hyperphenylalaninemia in the PAHenu2 mouse model of phenylketonuria
|
Dobrowolski, S.F. |
|
2016 |
119 |
1-2 |
p. 1-7 7 p. |
artikel |
8 |
Editorial Board
|
|
|
2016 |
119 |
1-2 |
p. IFC- 1 p. |
artikel |
9 |
Elevated plasma dihydroorotate in Miller syndrome: Biochemical, diagnostic and clinical implications, and treatment with uridine
|
Duley, John A. |
|
2016 |
119 |
1-2 |
p. 83-90 8 p. |
artikel |
10 |
Epigenotype, genotype, and phenotype analysis of patients in Taiwan with Beckwith–Wiedemann syndrome
|
Lin, Hsiang-Yu |
|
2016 |
119 |
1-2 |
p. 8-13 6 p. |
artikel |
11 |
Expanding the phenotypic spectrum of Succinyl-CoA ligase deficiency through functional validation of a new SUCLG1 variant
|
Donti, Taraka R. |
|
2016 |
119 |
1-2 |
p. 68-74 7 p. |
artikel |
12 |
Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions
|
Davis, Margaret R. |
|
2016 |
119 |
1-2 |
p. 174-185 12 p. |
artikel |
13 |
Long-term endurance and safety of elosulfase alfa enzyme replacement therapy in patients with Morquio A syndrome
|
Hendriksz, Christian J. |
|
2016 |
119 |
1-2 |
p. 131-143 13 p. |
artikel |
14 |
Mitochondrial disease patients' perception of dietary supplements' use
|
Karaa, Amel |
|
2016 |
119 |
1-2 |
p. 100-108 9 p. |
artikel |
15 |
Mutations in TFAM, encoding mitochondrial transcription factor A, cause neonatal liver failure associated with mtDNA depletion
|
Stiles, Ashlee R. |
|
2016 |
119 |
1-2 |
p. 91-99 9 p. |
artikel |
16 |
Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model
|
Hinderer, Christian |
|
2016 |
119 |
1-2 |
p. 124-130 7 p. |
artikel |
17 |
221 newborn-screened neonates with medium-chain acyl-coenzyme A dehydrogenase deficiency: Findings from the Inborn Errors of Metabolism Collaborative
|
Bentler, Kristi |
|
2016 |
119 |
1-2 |
p. 75-82 8 p. |
artikel |
18 |
Patients' perspectives on newborn screening for later-onset lysosomal storage diseases
|
Lisi, Emily C. |
|
2016 |
119 |
1-2 |
p. 109-114 6 p. |
artikel |
19 |
Physical therapy management of infants and children with hypophosphatasia
|
Phillips, Dawn |
|
2016 |
119 |
1-2 |
p. 14-19 6 p. |
artikel |
20 |
Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study
|
van der Ploeg, Ans |
|
2016 |
119 |
1-2 |
p. 115-123 9 p. |
artikel |
21 |
Rapid detection of G6PD mutations by multicolor melting curve analysis
|
Xia, Zhongmin |
|
2016 |
119 |
1-2 |
p. 168-173 6 p. |
artikel |
22 |
Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry
|
Hopkin, Robert J. |
|
2016 |
119 |
1-2 |
p. 151-159 9 p. |
artikel |
23 |
Table of Contents
|
|
|
2016 |
119 |
1-2 |
p. iii-v nvt p. |
artikel |
24 |
The M405V allele of the glutaryl-CoA dehydrogenase gene is an important marker for glutaric aciduria type I (GA-I) low excretors
|
Schillaci, Lori-Anne P. |
|
2016 |
119 |
1-2 |
p. 50-56 7 p. |
artikel |
25 |
Unravelling 5-oxoprolinuria (pyroglutamic aciduria) due to bi-allelic OPLAH mutations: 20 new mutations in 14 families
|
Sass, Jörn Oliver |
|
2016 |
119 |
1-2 |
p. 44-49 6 p. |
artikel |